Viant Said to Explore Sale That Might Fetch About $3 Billion (1)

April 1, 2022, 4:59 AM UTC

Medical device maker Viant is exploring strategic options including a potential sale that could value it at $2 billion to $3 billion and perhaps more, according to people familiar with the matter.

The company, backed by health-care focused private equity firm Water Street, has been talking to advisers and a sale process could begin this year, said the people, who asked not to be identified because the discussions were private. The company, based in Foxborough, Massachusetts, generates $200 million a year in earnings before interest, taxes, depreciation and amortization, the people said.

Viant is expected to draw takeover interest ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.